Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Y Wo

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Pancreas|May 21, 2021
Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective StudyGrace Lee, Daniel W Kim, Oluwadamilola T Oladeru, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapyJona A Hattangadi-Gluth, Jennifer Y Wo, Paul L Nguyen, et al.
Cancer|September 6, 2013
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010Sophie Cai, Theodore S Hong, Saveli I Goldberg, et al.
European Radiology|October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapyYoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Annals of Surgical Oncology|October 3, 2018
Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?Winta T Mehtsun, Fallon E Chipidza, Carlos Fernández-Del Castillo, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)Benjamin D Smith, Douglas W Arthur, Thomas A Buchholz, et al.
Annals of Surgical Oncology|December 25, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAlicia C Smart, Lipika Goyal, Nora Horick, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Pancreas|May 21, 2021
Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective StudyGrace Lee, Daniel W Kim, Oluwadamilola T Oladeru, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapyJona A Hattangadi-Gluth, Jennifer Y Wo, Paul L Nguyen, et al.
Cancer|September 6, 2013
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010Sophie Cai, Theodore S Hong, Saveli I Goldberg, et al.
European Radiology|October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapyYoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Annals of Surgical Oncology|October 3, 2018
Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?Winta T Mehtsun, Fallon E Chipidza, Carlos Fernández-Del Castillo, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)Benjamin D Smith, Douglas W Arthur, Thomas A Buchholz, et al.
Annals of Surgical Oncology|December 25, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAlicia C Smart, Lipika Goyal, Nora Horick, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Pageof 15